Remarkably, Gene Set Enrichment (GSE) unveiled a significant upregulation of USP39 mRNA levels from monoclonal gammopathy of undetermined significance (MGUS) to the MM stage, compared to healthy individuals. This evidence concerns the gene USP39 and Miyoshi myopathy.